We sought to conduct a randomized trial comparing late revascularization with conservative therapy in symptom-free patients after acute myocardial infarction (AMI). BACKGROUND In the absence of ischemia, the benefits of reperfusion late after AMI remain controversial.
The benefits of early reperfusion in acute myocardial infarction (MI) involve infarct size reduction, preservation of left ventricular (LV) function, and increased survival (1) . By contrast, the role of late reperfusion, beyond the window for myocardial salvage, remains controversial. The potential mechanisms of benefit attributable to late reperfusion, which are largely hypothetical and/or poorly characterized, fall collectively under the umbrella of the "open artery hypothesis" (2) . Despite a lack of consensus, late mechanical reperfusion after MI seems to be a common treatment strategy.
Clinical interest in the open artery hypothesis (3) stemmed from sub-group analyses demonstrating appreciable survival, compared with placebo-matched controls, in patients with MI receiving streptokinase Ͼ12 h after symptom onset (1, 4) . Subsequent thrombolytic studies powered specifically to address the role of late reperfusion, however, failed to confirm these initial observations (5) . More recently, interest in the open artery hypothesis has resurfaced as safer and more effective mechanical revascularization practices have emerged. Although observational data suggest a role for late intervention (6) , the results of randomized trials are inconclusive (7) (8) (9) . One recent trial (10) , however (albeit with incomplete follow-up and relatively high rates of restenosis), has shown long-term clinical benefits from balloon angioplasty late after MI and thus suggests that late-presenting patients, or those with failed thrombolysis, may still benefit from percutaneous coronary intervention (PCI) by mechanisms independent of myocardial salvage.
We therefore addressed this issue by conducting a prospective randomized trial comparing medical therapy with late PCI (including stents) in symptom-free patients with LV dysfunction after anterior MI associated with a proximal occlusion of the left anterior descending (LAD) coronary artery.
METHODS
The Open Artery Trial protocol is shown in Figure 1 .
Patient selection.
Patients presenting to a recruitment center between March 1997 and June 1999 with an acute transmural anterior wall MI were enrolled. Selection criteria included the following: 1) age Յ75 years; 2) an uncomplicated hospital course, including absence of post-infarction angina or cardiogenic shock; 3) sinus rhythm without bundle branch block; 4) echo-derived ejection fraction Ͻ50%, or Ն3 pathological Q waves in the precordial ECG leads; and 5) absence of chest pain, ECG change, or hemodynamic disturbance during modified Bruce treadmill exercise test. Written informed consent and subsequent procedures were approved by our Institute's ethical committee. Screening coronary angiography. Coronary angiography was performed between three days and four weeks of MI using standard Judkins technique. Patients with an occluded LAD coronary artery (Thrombolysis In Myocardial Infarction [TIMI] flow grades 0 or 1) (11) and non-significant disease elsewhere (Յ50% stenosis) were randomized. Randomization. Patients were assigned to either medical therapy alone (closed artery group) or PCI plus stent to the LAD artery in addition to medical therapy (open artery group). Randomization was performed with customized software (MINIM shareware; S.J. Evans et al; The London Hospital Medical School, London, UK) with matching for six pre-defined variables likely to influence remodeling: 1) age (Յ50 or Ͼ50 years); 2) gender (male or female); 3) systolic blood pressure (Ն100 or Ͻ100 mm Hg); 4) use of oral beta-adrenergic blocker therapy; 5) use of angiotensinconverting enzyme inhibitor (ACE-I) therapy; and 6) LV end-systolic volume (ESV) (Յ60, 61 to 80, 81 to 100, or Ͼ101 ml). Percutaneous coronary intervention. These procedures were performed using standard techniques, either at the time of or within two weeks of angiography (overall between three days and six weeks of MI). NIR stents (Boston Scientific Corporation; Quincy, Massachusetts) were recommended, although selection of guidewires, balloons, inflation pressures, stent sizes, and use of adjunctive therapies were left to the discretion of the operator. Angiographic success was defined as the restoration of TIMI flow grades 2 or 3 in the infarct artery together with Ͻ50% residual stenosis. Post-procedural quantitative coronary angiographic assessments were performed off-line with commercial software (Quantim systems, Quinton, Seattle). Medical treatment after randomization. Optimal medical therapy for all patients included drugs known to carry prognostic benefits after MI: 1) aspirin; 2) beta-blockers; 3) ACE-I; and 4) lipid-lowering agents to maintain total cholesterol level Ͻ4.8 mmol/l. In addition, stented patients received clopidogrel and higher-dose aspirin for two weeks post procedure. Patient follow-up. Patients presented at six weeks, three months, six months, and 12 months post MI for echocardiographic estimates of LV size and function and for assessments of exercise tolerance and quality of life (QoL). In addition, at the final 12-month visit, repeated coronary angiography was performed to re-assess coronary artery patency.
LEFT VENTRICULAR FUNCTION.
Left ventricular function was assessed by echocardiography (Hewlett Packard sonos 2500 or Advanced Technology Ltd HDI 3000). Estimates of LV ESV, end-diastolic volume (EDV), and ejection fraction (EF) were obtained from the average of three consecutive cardiac cycles taken from apical four chamber views using the modified Simpson's rule. Measurements were performed off-line (VingMed system 5 with in-built analysis pack) by two blinded echocardiographers after calibrating for each study. Final values for LV ESV, EDV, and EF represent the mean of the values of the two independent reporters. EXERCISE TOLERANCE. Patients underwent maximal treadmill testing using the Bruce protocol. Tests were conducted by a blinded technician who recorded exercise duration (min) and maximal cardiac workload (peak rate pressure product; mm Hg/min).
QOL.
A generic QoL tool, the Nottingham Health Profile (NHP), was self-administered (12) . Study end-points and sample size calculations. Left ventricular ESV is a sensitive measure of post-infarction LV remodeling and one of the most powerful predictors of long-term prognosis after MI (13) . Furthermore, attenuation of post-infarction LV dilation is thought to be an important contributing mechanism to the open artery hypothesis (2). The Open Artery Trial was therefore designed to compare LV ESV between the two study groups of patients at highest risk of adverse LV remodeling (transmural anterior MI).
To date, two prospective randomized trials examining the open artery hypothesis have reported serial changes in LV ESV (9, 10) . Data from the former study were available for the present power calculations. In addition, a Medline search identified eight observational studies reporting relationships between infarct artery patency and subsequent LV ESV (14 -21). Using the formula for the comparison of two means (unpaired data), sample sizes were calculated on the basis of: 1) an anticipated 30% reduction of LV ESV at 12 months in the open artery group; 2) the statistical significance of 0.05; and 3) a power of 80%. Sample size estimates of 58 patients (weighted mean of observational studies) and 54 patients (randomized study) were calculated. The larger estimate was used in the design of the present study. Statistical analysis. Data (mean Ϯ SD) were analyzed on an intention-to-treat basis using SigmaStat v2.03 (incorporating SPSS). After data passed normality and equal variance tests, two-way repeated measures analyses of variance were applied to determine differences in end points by time post MI and study group allocation. Post hoc Tukey tests were used to compare between-group differences at six weeks and 12 months post MI. Non-parametric data were compared with the Fisher exact test. A p value Ͻ0.05 was considered statistically significant.
RESULTS

Patient recruitment and baseline characteristics.
Over the 28-month recruitment period, 223 patients meeting the selection criteria were referred for angiography (Fig. 1 ). Baseline characteristics (Table 1 ) of randomized patients were similar apart from a trend toward a higher prevalence of diabetes in the open artery group. All patients enrolled in the study received, and tolerated, lisinopril, 10 mg/day. Twenty-six patients in the open group and 29 in the closed group were given beta-adrenoceptor blockers in the form of atenolol. At six weeks, the resting heart rate and systolic and diastolic blood pressures in the open and closed group were, respectively, 72.7 Ϯ 13.3 versus 74.8 Ϯ 10.2 beats/min, p ϭ 0.5; 129.9 Ϯ 18.5 versus 127.6 Ϯ 16.5 mm Hg, p ϭ 0.6; and 78.9 Ϯ 11.9 versus 77.3 Ϯ 9.0 mm Hg, p ϭ 0.5.
Results of intervention.
Results of PCI are given in Table  2 . The procedure was successful in 30 patients (94%). In one patient, the lesion could not be crossed, while in the other, a highly calcific lesion precluded stent implantation, although the angioplasty itself was successful. There was one procedural adverse event with re-infarction occurring 18 h after intervention. Repeated angiography confirmed stent thrombosis that was successfully treated with an infusion of a platelet GPIIb/IIIa receptor antagonist and repeated angioplasty to the occluded segment. Follow-up angiography. Patients underwent follow-up angiography 52.9 Ϯ 4.7 weeks post randomization. Reocclusion (TIMI grades 0 or 1 flow) occurred in three (11.1%) and restenosis (Ͼ50% diameter stenosis) in five (18.5%) patients. In addition, spontaneous recanalization (ՆTIMI 2 flow) occurred in six (18.6%) patients randomized to the closed artery group (Table 2) . (Fig. 2) . (Fig. 3) . Over the follow-up period, exercise duration significantly increased in both groups, but this was greatest in the open group. Quality of life. No significant differences between the two groups were observed at six weeks (Fig. 4) . The NHP part I scores (reflecting self-perceived QoL) significantly increased over time in the closed artery group (p Ͻ 0.01) and remained unchanged in the open artery group. The difference in the two groups at 12 months, however, was not significant. The NHP part II scores (reflecting impact on lifestyle) tended to increase (closed artery) and decrease (open artery) over time. At 12 months, late intervention was associated with significantly less functional impairment. Clinical events. The clinical events are described in Table  3 . The two deaths in the open artery group occurred between six and eight months post MI; both were sudden, with no definite underlying cause identified at post-mortem examination. The death in the closed artery group occurred three months post MI and was due to progressive arterial disease being immediately preceded by re-infarction, stroke, and circulatory failure. Of the three re-infarctions in the open artery group, one was related to the percutaneous transluminal coronary angioplasty procedure and the other two occurred six to eight weeks post procedure. Electrocardiographically, all were in the LAD territory, and repeated 
DISCUSSION
We have demonstrated that while late intervention to open occluded infarct-related arteries in patients after transmural anterior MI is technically feasible, this strategy is associated with significantly greater LV dilation than a non-invasive strategy. The strategy of late intervention, however, may lead to an improved QoL and increased exercise tolerance.
Our results contrast with an earlier report in similar patients showing significantly reduced clinical events and beneficial effects on LV function after late PCI (10) . Of note, however, other larger studies comparing late intervention with conservative management in patients after MI have not demonstrated superiority of either strategy with respect to clinical outcome (7, 22) . Furthermore, our results are consistent with those of Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-6) trial in which, although no significant differences in LV ESV at six months were observed between patients undergoing late PCI and patients 
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Effect of Late Reperfusion treated medically, absolute ESV increased by 9% in the interventional group and decreased by 13% in the medical group (9). During follow-up, the incidence of five pre-defined clinical events was also recorded in the current study as part of a secondary efficacy measure. Table 3 illustrates the combined clinical events. Our combined event rate also favors a policy of conservative therapy, with a 44% increased risk of suffering an adverse event in patients undergoing late PCI.
Of the three re-infarctions in the open artery group, one was directly related to the interventional procedure, and the other two occurred six and eight weeks after intervention. Mechanisms other than sub-acute stent thrombosis (e.g., regression of pre-existing collateral vessels) may therefore underlie these events (see description under possible adverse effects) (23) . The two sudden deaths in the open artery group (six and eight months after MI) are attributed to arrhythmic causes. Although late reperfusion has been shown to favorably alter the arrhythmic substrate with respect to the prevalence of ventricular late potentials (24) , there is also the possibility that late reperfusion may promote a pro-arrhythmic environment by maintaining islands of viable cells within a fibrotic scar (25) . This remains an important clinical issue in need of further investigation.
Timing of late reperfusion may be an important factor. Pfisterer et al. (26) , for example, reported significant attenuation of LV dilation in patients undergoing intervention two to three weeks after MI but not in patients undergoing the same procedure three months later. One-third of patients in the present study underwent PCI between 3 and 7 days of MI, while in another one-third it was between 36 and 42 days. The LV ESV changes between 6 weeks and 12 months of MI in the two sub-groups, however, were similar. Thus, in the present study, neither the direction nor the amplitude of the changes in LV ESV was dependent on the timing of PCI. However, since PCI was not performed in the first three days after MI, we cannot rule out the presence of an early time-dependent benefit. Possible adverse effects of late PCI after MI. There is increasing evidence that after a large MI, the distal microcirculation has a high resistance, leading to low-reflow and stasis within the epicardial vessel (27) . Thus, an occluded infarct-related artery may indicate high microvascular resistance. Intervention in this situation would therefore not be expected to carry any appreciable benefits. A similar explanation may explain the lack of advantage of fibrinolytics in combination with IIb/IIIa receptor blockers over fibrinolytics alone, despite a markedly higher prevalence of infarct artery patency (28) .
In the setting of an occluded infarct vessel, distal ischemic myocardium is often supported by collateral vessels. After intervention, collateral vessels may become embolized, and this may be one mechanism contributing to the documented and rapid regression of recruitable collateral support after PCI for total occlusions (23) . Interestingly, the two open artery patients in our study who had re-infarctions six to eight weeks after PCI were found to have well developed collateral vessels at the time of their initial intervention (Rentrop grades 2 and 3, respectively). Angiography shortly after re-occlusion, however, failed to show significant collateral support. Medical treatment in the two study groups was standardized. After stent deployment, however, patients received clopidogrel together with high-dose aspirin for two weeks. An adverse remodeling effect from increased antiinflammatory activity in the open artery patients cannot be excluded (29, 30) , but seems unlikely, given the known benefits of this combination (31) . QoL and exercise tolerance after late intervention. Despite our findings of significant LV dilation in patients treated with late intervention, QoL and exercise tolerance either tended to, or actually, improved in these patients. The NHP is a sensitive tool that has been validated for use in patients with cardiovascular disease. Previously, for example, it was utilized to compare angioplasty with surgery in patients with coronary artery disease, in which both invasive strategies were shown to result in improved QoL (32) . More recently, in a thrombolytic study, health-related QoL was assessed in more than 1,800 patients by telephone interview using a combination of various questionnaires. Interestingly, health-related QoL was found to relate to early LV ejection fraction (myocardial salvage), but not infarct artery patency (33) . Study limitations. Our study has several limitations. First, this is a small study powered to compare only LV ESV. Second, echocardiographic estimates of LV volume post MI are disturbed by various assumptions. Third, although micro-embolization may represent a potential mechanism that contributed to the lack of benefit in the open artery group, we did not formally assess the extent of periprocedural micro-infarction by routine measurement of cardiac enzymes. Fourth, although we excluded patients with a positive exercise test early after MI, we cannot exclude a selection bias in terms of residual myocardial viability. Fifth, as evidenced by the exclusion in Figure 1 , our study population was highly selected, limiting the generalizability of our findings. Finally, the role of the micro-vascular circulation is inadequately addressed. Future studies combining the use of platelet IIb/IIIa receptor antagonists and pressure wires may help clarify this issue. Clinical implications. Observational data show that sustained infarct artery patency after MI confers long-term benefits. Our study, however, demonstrates that although late intervention after MI is technically feasible, in our highly selected patient group, it is associated with significant LV dilation compared with medical therapy. Thus, patients remaining symptom-free after MI may not derive objective benefits from late mechanical revascularization. If such procedures are considered in this patient group, they should be within the context of ongoing clinical trials.
